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ABSTRACT
Purpose: To examine 30-day mortality and National Cancer Institute (NCI) designation for
cancer patients who are immunocompromised and hospitalized. Method: Secondary analysis
of 1998 and 1999 hospital claims, cancer registry, and vital statistics (n = 10,370) linked to
survey and administrative data from 160 Pennsylvania hospitals. Logistic regression models
estimated the effects of NCI designation on the likelihood of 30-day mortality. Results: NCI-
designated centers were associated with a 33% reduction in the likelihood of death, after
adjusting for patient, hospital, and nursing characteristics. Conclusions: Immunocompromised
cancer patients have lower mortality in NCI-designated hospitals. Identification and adoption
of care processes from these institutions may improve mortality.
INTRODUCTION
Neutropenia related to the treatment of cancer is a frequent
patient complication. A prospective observational study of pa-
tients undergoing active chemotherapy reported the frequency
of febrile neutropenia at 10.4%, with significant variations ob-
served based on tumor type, chemotherapy administered, and
patient characteristics (1).
Febrile neutropenia—defined as the presence of fever at
or above 38.0◦C and an absolute neutrophil count below
1,000 cells/mm3—is considered an oncologic emergency (2).
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For several decades, clinical instruction to physicians, nurses,
and pharmacists stressed the necessity of prompt assessment,
performance of diagnostic studies, such as blood cultures, and
the administration of broad-spectrum anti-infectives (3). Despite
these efforts, complications and mortality from this problem still
occur with notable frequency. In two recent studies, the average
inpatient mortality estimates for this complication were 6.8%
(4) and 9.5% (5). Notable variation in mortality was observed
based on the severity of illness.
In 2007, the Oncology Nursing Society convened a state-
of-the-knowledge symposium on the management of febrile
neutropenia (6, 7). The goals of this symposium were to under-
stand the clinical and research advances in the understanding of
neutropenia in patients with cancer, to summarize the current
clinical landscape, and to disseminate evidence-based preven-
tive and management strategies to clinicians throughout the
United States. Salient findings from this symposium were (a)
an underdeveloped research infrastructure to study the problem,
(b) strong evidence for the use of risk assessment models
to estimate probabilities of febrile neutropenia and related
complications, and (c) a wide variation in practice standards for
prevention and management of neutropenia in the United States.
Variation in clinical practice and quality outcomes is a
























































Quality Board has described the cancer care in the United
States as “uneven” (8). Health service researchers have sought
to explain variations in outcomes by an array of patient and hos-
pital characteristics. One such endeavor, by our research team,
elucidated the relationships among mortality, characteristics
of hospitals (e.g., bed size, teaching intensity), and character-
istics of nurses (e.g., staffing, educational preparation). In a
sample of surgical oncology patients, we identified significant
associations between 30-day mortality and characteristics
of hospitals and nursing care (9). Other investigators have
identified hospital characteristics associated with surgical
oncology outcomes (10, 11). Similar investigations have not yet
been published for patients with cancer who are hospitalized
and immunocompromised.
From a conceptual perspective, researchers have hypothe-
sized that patients with significant clinical complexity, as well
as relatively frequent use of health care services, are most likely
to benefit from organizational characteristics that foster excel-
lent care delivery (12). Below, we present data to examine this
hypothesis in a sample of patients with cancer, who are hospital-
ized and immunocompromised. For purposes of this analysis, we
define immunocompromised patients as those with a confirmed
cancer diagnosis, and either a diagnosis of agranulocytosis on
inpatient claims or the combination of fever and leucopenia
(<3,000/mm3). These findings have implications for the cur-
rent state of health care delivery for these patients, as well as
informing a future research agenda on reducing needless varia-
tion in mortality from cancer-related complications.
METHODS
After human subjects exempt review by the University of
Pennsylvania’s institutional review board, we performed sec-
ondary analysis of linked data created by merging inpatient
claims from the Pennsylvania Health Care Cost Containment
Council (PHC4), the Pennsylvania Cancer Registry, and the
American Hospital Association annual survey data. The list
of National Cancer Institute’s (NCI) (13) clinical and com-
prehensive cancer centers available from their Web site was
used to identify hospitals in the sample with those designations
in 1998–1999. Details of the linkage procedure have been re-
ported elsewhere (9). Consistent with prior studies, we identified
patients with neutropenia by an International Classification of
Diseases, 9th edition (ICD-9) diagnosis code of 288.0 present in
the claims record (4, 5). Because of augmentation of our claims
data with elements abstracted from the clinical chart (described
in more detail below), we included 1,309 patients with a combi-
nation of a white blood cell count value below 3,000/mm3 and
the presence of a temperature ≥38.0◦C, both recorded in the
medical record within the first three days of admission (granu-
locyte counts were not available). Because we could not iden-
tify with certainty these patients were neutropenic, the term
immunocompromised will be used to describe the sample.
Our analytic sample included 10,370 adults with a confirmed
cancer diagnosis treated in 160 acute care hospitals in 1998 and
1999. To clarify examination of outcome differences attributable
to organizational characteristics, we excluded 65 patients who
died on the day of admission, and 722 patients who were hos-
pitalized in facilities with missing organizational variables.
Definition of variables
30-day mortality
We obtained dates of death through the linkage of death
records to the cancer registry and inpatient claims records. We
defined 30-day mortality as the number of patients who died
within 30 days following the date of hospital admission. When
available, 30-day mortality rates are preferred to inpatient mor-
tality rates, as the latter may be biased due to known differences
in hospital length-of-stay and discharge profiles.
Patient characteristics
Adjustment for patients’ underlying severity of illness is nec-
essary to examine the effects of organizational characteristics
on mortality. To accomplish this task, variables to measure pa-
tient characteristics were obtained from the hospital claims file,
the cancer registry record, and from the clinical data abstracted
during the first three days of hospitalization.
On the basis of an existing approach to measure patient char-
acteristics (14), we constructed an algorithm to detect comor-
bidities from claims data up to 90 days preceding the studied
admission, and each comorbidity was treated as a dichotomous
variable. To improve model fit, age at the time of hospitalization
was measured as both a linear and quadratic term. We obtained
pathologically confirmed tumor diagnoses from the cancer reg-
istry record, and tumor type was treated as a categorical variable
for the range of tumors studied.
By state regulations, each hospital admission in Pennsylva-
nia was abstracted routinely by trained medical record coders
for key clinical findings (KCFs) to construct the AtlasTM (for-
merly known as MEDISGRPS) severity of illness score (15,
16). KCFs are data elements obtained from the first three days
of the inpatient medical record; these reflect abnormal physical
signs, laboratory values, and radiology or diagnostic cardiology
results. In contrast to usual methods of measuring severity us-
ing solely diagnosis and procedure codes, an oncology nurse
and an oncologist identified KCFs relevant to cancer patients
and created a series of binary variables. For example, a patient
may have had a KCF value that reflected a hemoglobin level of
10.0 g/dL during the first three days of admission. This was
converted to a binary variable of anemia = yes.
Hospital characteristics
Hospital characteristics data were obtained by the Common-
wealth of Pennsylvania’s annual state survey of health care
facilities. Whenever possible, we selected variables studied
frequently in the literature that examines outcomes related to
organizational variables, and measured them similarly. Hospital
beds set up and staffed were categorized as 100 beds or fewer,
101–250 beds, 251 beds or higher (17). Hospitals that performed
solid organ transplants or open-heart operations in 1999 were























































coded as providers of “advanced procedures” (18). Prior stud-
ies have suggested that the provision of advanced technological
resources may have spillover benefits for other conditions (19).
We used the ratio of medical residents or fellows per bed set up
and staffed to categorize teaching status: Non-teaching hospi-
tals had no residents/fellows per bed; minor teaching hospitals
had a lower than 1:4 resident/fellow to bed ratio; major teaching
hospitals had at least one resident/fellow per four beds (20).
A dichotomous variable was created to identify hospitals des-
ignated by the NCI as a clinical cancer center, comprehensive
cancer center, or neither. At the time of this study, the NCI con-
ferred clinical cancer center designation to facilities with clinical
programs to support clinical trials, robust basic science research
programs with a cancer focus, and the satisfactory completion
of peer and site reviews. Comprehensive cancer center designa-
tion shared features of clinical cancer centers, with the addition
of required shared research resources, and an interdisciplinary
cancer control and population science research program.
Nursing characteristics
The data from claims and hospital administrative files were
compiled as part of a larger study originally designed to investi-
gate the relationship between nursing organizational characteris-
tics and patient outcomes. Data regarding nursing characteristics
were obtained from a mailed survey to a 50% random sample
registered nurses working in Pennsylvania between 1998 and
1999 (17). The overall response rate was 52%, which is similar
to the response rates to anonymous surveys of health care pro-
fessionals. Three characteristics of hospital nursing were mea-
sured in the current study: the nurse practice environment, nurse
staffing, and the educational preparation of registered nurses.
These measures were identical to those previously reported (9).
This study used the Practice Environment Scale of the Nurs-
ing Work Index (PES-NWI) to measure the perceived working
conditions of registered nurses in acute care hospitals (21). Items
on this scale reflect a nurse’s agreement that the selected char-
acteristic is present in their current job (1 = strongly disagree, 2
= disagree, 3 = agree, and 4 = strongly agree). Five subscales
comprising 31 items describe the practice environment of regis-
tered nurses in hospitals: Nurse Participation in Hospital Affairs
(e.g. “staff nurses have the opportunity to participate on hospi-
tal and nursing committees”); Nursing Foundations for Quality
of Care (“active inservice/continuing education programs for
nurses”); Nurse Manager Ability, Leadership, and Support of
Nurses (“a supervisory staff that is supportive of the nurses”);
Staffing and Resource Adequacy (“enough registered nurses to
provide quality patient care”); and Collegial Nurse–Physician
Relations (“physicians and nurses have good working relation-
ships”).
We aggregated values on PES-NWI items from individual
nurse responses to calculate hospital-level means of the PES-
NWI subscales. Hospitals were then assigned to one of three cat-
egories: unfavorable nurse practice environments (scores above
2.5 on zero or one subscale), mixed, (scores above 2.5 on 2–3
subscales), or favorable (scores above 2.5 on 4–5 subscales).
This classification has been supported by both validity and la-
tent class analysis (22).
To measure nurse staffing, survey responses from eligible
registered nurses were used to calculate a mean workload (num-
ber of patients cared for on the last shift) per hospital. Consistent
with prior analyses, outlier values on this measure (more than 6
patients cared for in intensive care units and 20 patients cared
for outside of intensive care units) were excluded. The mean
value of the number of patients cared for on the last shift was
used as a continuous measure in the final models.
To measure educational preparation of nurses, each eligible
staff nurse’s response to the question “what is the highest nursing
degree you have?” was used for analysis. For each hospital, we
calculated the proportion of nurses who held a baccalaureate
degree or higher. The proportion was treated as a continuous
measure.
Statistical analysis
First, we tested bivariate relationships for 30-day mortality
and characteristics of patients, hospitals, and nurses using the
appropriate t, F, or chi-square test. We examined correlation
matrices to identify high correlations, and calculated variance
inflation factors and tolerance values to diagnose multicollinear-
ity among nursing and hospital characteristics.
To construct severity of illness models, we first estimated
logistic regression models to predict 30-day mortality using the
available patient characteristics. Split-sampling methodology
was used to increase the stability of obtained parameter esti-
mates. In a random 50% sample of study patients, 192 logistic
regression models were estimated to predict 30-day mortality
for each candidate patient characteristic. We used the purpose-
ful selection algorithm described by Bursac and colleagues (23)
to guide the final variable selection. Briefly described, univari-
ate models were estimated to identify variables significantly
associated with 30-day mortality at p < .25. Iterative multi-
variate models were then estimated for evidence of significance
at p < .10 and changes to parameter estimates that exceeded
20%. The model was finally replicated in the remaining 50%
of the sample, with no corresponding differences in parame-
ter estimates and statistical significance observed. The retained
63 variables reflected demographics, clinical findings on ad-
mission, comorbidities, and cancer information. The C statistic
enabled us to compare the discriminatory power of our severity
of illness models (24). The C statistic of our final severity of
illness model was 0.82. The variables and the corresponding
odds ratios for the likelihood of 30-day mortality are available
in the Appendix. Briefly summarized, these variables may be
categorized into age, tumor type, conditions present on admis-
sion, comorbidities, abnormal laboratory values, vital signs, or
physical examination findings.
Following the estimation and validation of the severity ad-
justment model, we then performed a patient-level analysis and
estimated a series of logistic regression models to predict 30-day
mortality. First, models estimated the effect of each hospital and
nursing characteristic with the patient characteristics selected























































from the severity adjustment model. After these models were
examined for significant results, our final models considered all
patient severity measures described above, plus a reduced set
of nursing and hospital characteristics simultaneously. Robust,
cluster methods were specified in STATA version 10.0 (STATA
Corp, College Station, Texas) to adjust standard errors and ac-
count for patient clustering in hospitals (25, 26). Coefficients
were transformed to odds ratios (OR), and 95% confidence in-
tervals (95% CI) were calculated for all parameter estimates.
Finally, we compared hospital and nursing characteristics by
organizational characteristics of significance in our final model
by calculating means and frequencies.
RESULTS
Patient characteristics
Table 1 shows the characteristics of the study sample (n =
10,370 in 160 hospitals). The mean age was approximately 62
years, with a range between 21 and 98 years of age. A rela-
tively low proportion of non-white patients were in this sam-
ple, which is characteristic of Pennsylvania’s demographics.
Nearly half of all patients had metastatic disease at the time of
Table 1. Patient Characteristics of the Study Sample, N = 10,370
Mean (SD) Range
Age (years) 61.6 (14.2) 21–98
n %
Female 5,600 54.0
Year of hospitalization 1998 5,621 54.2
1999 4,749 45.8
Non-white ethnicity 1,161 11.2
Cancer stage Regional 2,183 21.2
Distant 4,870 47.0




Colorectal and anal 959 9.3
Other GI tumor 715 7.0
Ovarian 428 4.1
Prostate 382 3.7
Other gynecological 266 2.6
Other genitourinary 238 2.3
















diagnosis. While a third of patients had hematological malig-
nancies, 18% had lung cancer, and over 12% had breast can-
cer. Approximately 14% of the sample died within 30 days of
admission.
The association between 30-day mortality and nursing and
hospital characteristics is shown in Table 2. The left-hand-side
panel displays calculated ORs and 95% confidence intervals
(95% CIs) calculated from seven separate multivariate logistic
regression models. Each characteristic displayed was entered
into a model with all 63 patient variables to estimate the like-
lihood of 30-day mortality. (To conserve space, the calculated
ORs for each patient characteristic were suppressed from the ta-
ble, but these are available from the authors.) Receipt of care in
an NCI-designated comprehensive cancer center was associated
with a 37% decrease in the likelihood of mortality within 30
days of admission, after adjusting for all 63 patient character-
istics (Model I). In Model II, care received in a minor teaching
hospital—when compared with a non-teaching hospital—was
associated with a significant decrease in the likelihood of mor-
tality (OR 0.81, 95% CI 0.67–0.98). The other characteristics
studied, namely nurse staffing, nurse educational preparation,
nursing practice environment, performance of advanced pro-
cedures, and bed size, were not significantly associated with
mortality.
The right-hand side of Table 2 shows results from one logistic
regression (Model VIII) estimating the likelihood of mortality
with a reduced set of hospital and nursing characteristics, plus
all 63 patient characteristics from the severity of illness model
(output suppressed). The only characteristic significantly asso-
ciated with mortality was receipt of care in an NCI-designated
cancer center (OR 0.67, 95% CI 0.47-0.93).
Given the significant effects of NCI cancer centers observed,
we compared the hospital and nursing characteristics by NCI
status (Table 3). Inferential statistics are not provided because
of the imbalance in the exposure variable. All NCI cancer cen-
ters in the sample performed advanced procedures, such as solid
organ transplant or coronary artery bypass graft surgery, com-
pared with 35% of non-NCI hospitals. Nurses in NCI hospitals
reported more favorable working conditions, as measured by the
PES-NWI subscales, than those in non-NCI hospitals. Similarly,
staffing and educational preparation were higher in NCI facili-
ties. NCI-designated hospitals were larger and had substantially
higher proportions of fellows and residents per bed.
In a further attempt to explain our primary significant finding,
we also examined differences in patient characteristics by NCI
cancer center status. We observed a significant age difference
(mean 62.1 years in non-NCI hospitals versus 54.0 in NCI hos-
pitals, p < .001). More cases of regional cancer stage were found
in non-NCI hospitals (21.5% versus 17.5%, respectively, p <
.01). However, no significant difference in distant or metastatic
stage was observed (46.7% in non-NCI versus 49.8% in NCI
hospitals, p = .06). Of the 61 other deleterious patient char-
acteristics used for risk adjustment, 20 were significantly more
frequent in non-NCI hospital patients, while 7 were significantly
more frequent in NCI hospital patients.























































Table 2. Results From Multivariable Logistic Regression Models Estimating the Likelihood of 30-Day Mortality
Marginal Models Partial Model
Model Variable OR 95% CI Model OR 95% CI
I NCI designation 0.63 0.45 0.96 VIII 0.67 0.47 0.93
II Teaching
Non-teaching – – – – – –
Minor teaching 0.81 0.67 0.98 0.83 0.69 1.01
Major teaching 0.80 0.62 1.02 0.94 0.65 1.38
III Number of RNs/patient 1.05 0.98 1.14 1.01 0.93 1.09
IV ≥ 50% RNs with BSN or higher 0.88 0.72 1.07 0.97 0.74 1.26
V Nursing practice environment
Unfavorable – – – – – –
Mixed 1.00 0.68 1.46 0.97 0.65 1.46
Favorable 0.87 0.56 1.35 0.89 0.58 1.38
VI Performed advanced procedures 0.87 0.73 1.04
VII Size
<100 beds – – –
100–250 beds 1.21 0.88 1.65
> 250 beds 1.09 0.80 1.50
Note: Marginal models estimate the effect of each hospital or nursing characteristic on the likelihood of 30-day mortality, with 63 patient
characteristics from the severity model as covariates. The partial model estimates the effects of hospital, nursing, and 63 patient characteristics on
the likelihood of 30-day mortality simultaneously. Odds ratios from patient characteristics are suppressed. OR = Odds ratio; CI = Confidence
interval; NCI = National Cancer Institute; RNs = Registered nurses; BSN = Bachelor’s of science in nursing.
DISCUSSION
In this state-based sample of adults hospitalized with cancer
who are immunocompromised, the calculated 30-day mortal-
ity rate exceeded 14%. After considering severity of illness
with 63 patient characteristics, significant mortality variations
were observed by NCI cancer center designation and hospital
teaching status. However, when these characteristics were ex-
amined simultaneously, and in conjunction with other character-
istics of hospitals and of nurses, NCI cancer center designation
Table 3. Characteristics of Nurses and Hospitals by NCI Cancer
Center Designation
Characteristic NCI Designation




55 (35.3) 4 (100.0)
Nursing practice
environment
Unfavorable 12 (7.7) –
Mixed 113 (72.4) 2 (50.0)
Favorable 31 (19.9) 2 (50.0)
Mean (SD)
Number of RNs/patients 5.6 (1.2) 4.2 (0.4)
RNs who hold bachelor’s
degree or higher
35.7% (12.2) 61.1% (20.8)
Number of beds 216.7 (130.3) 526.0 (305.3)
Residents and
fellows/beds (%)
7.0 (13.7) 70.5 (52.5)
Note: Inferential statistics not provided due to imbalance between
comparison groups.
remained significantly associated with mortality. An examina-
tion of hospital, nursing, and patient characteristics suggests that
NCI hospitals differed notably from the rest of the sample on
the variables available for analysis.
Our mortality estimates are close, if not slightly higher than
previously published reports. This is most likely due to our
availability to examine death within 30 days of hospital admis-
sion, which will include a number of patients who die outside
of the hospital. These data are not routinely available in claims
data, unless they are linked to vital statistics. Health service re-
searchers have examined both in-hospital and 30-day mortality,
and generally recommend the latter measure, to account for dif-
ferences by hospital in length of stay and disposition patterns
(27).
While mortality associated with cancer-related neutropenia
has been studied extensively, we were not able to find any studies
that attempt to explain the variation in mortality by treating insti-
tutions. In our analysis, we identified one characteristic—NCI
cancer center designation—that was persistently and signifi-
cantly associated with a lower likelihood of death. There are
several potential explanations for our findings. First, while we
attempted to measure the hospital and nursing characteristics
that pervade the hospital outcomes literature, additional charac-
teristics of hospitals may be important to consider. The depth
of support from pharmacy, emergency medicine, infectious dis-
ease, radiology, and microbiology departments may be impor-
tant considerations for this specific patient population. In addi-
tion, we were unable to measure the quality of care delivered
prior to the hospital episode. This care is likely to have occurred
in outpatient settings, where claims data are not routinely avail-
able. It is also likely that patients who were clinically unstable
and live remotely may not be able to travel to the NCI centers























































for care, thus increasing the likelihood for poor outcomes in
non-NCI centers.
We observed significant differences in patient characteristics
between NCI and non-NCI hospitals. However, these charac-
teristics were included in our final analyses as covariates. It is
also possible that there may be differences in patients for char-
acteristics (such as depth and duration of neutropenia, do-not-
resuscitate status, election for palliative care, cause of death) that
are not available in these data. Thus, selection bias in patients
cannot be excluded as an explanation for our findings. However,
it is likely that patients in NCI cancer centers are more likely to
receive chemotherapy at higher dose intensities than non-NCI
centers. Confirmation of our findings with datasets that possess
more granular patient detail would be a welcome addition to the
literature. An analytic approach to address unmeasured patient
severity of illness would include the use of instrumental variable
analysis to identify characteristics that increase the proclivity of
care receipt in NCI hospitals, yet are not associated with mortal-
ity. An example of this would be a patient’s geographic distance
to an NCI cancer center. Regrettably, geographic location was
not available in our patient dataset.
Another reason for our principal finding is that the pa-
tients studied were too ill at presentation to benefit from
organization–outcomes relationships, contrary to the previous
hypothesis. If so, the emphasis for research and practice should
be on studying processes of care (e.g., prompt antibiotics, as-
tute assessment and interventions for aberrant findings, and
evidence-based sepsis management), rather than organizational
characteristics. Strengthening efforts by training providers to
identify patients at risk for this complication, and providing
early intervention, may also mitigate poor outcomes.
When the persistent and significant effect of NCI cancer cen-
ters is considered, we attempted to examine possible correlates
of this designation. On average, NCI hospitals were larger, bet-
ter staffed, had more nurses holding at least a bachelor’s degree,
had a tenfold higher teaching intensity, and performed advanced
procedures. However, these variables explained very little of the
outcome variation. This compels researchers to study the organi-
zational and clinical processes in place in NCIs that enable them
to have better outcomes for this problem. It appears that hospitals
with extensive human resources perform better for this patient
population, suggesting that the additional investments to sup-
port NCI designation convey a benefit to patients. However, the
majority of patients in the United States are not able to receive
care in an NCI-designated center, and a part of the original mis-
sion was to disseminate cancer research findings to community
clinicians (28). We are unable to examine the extent that knowl-
edge regarding management of these patients is shared between
NCI and other settings; this is a ripe area for future research.
One clinical practice recommendation is a more careful de-
cision analysis to admit patients to the hospital for this compli-
cation in the first place. Despite a strong body of evidence that
supports outpatient management of febrile neutropenia for pa-
tients at low risk for complications (29–36), this evidence-based
approach has not been widely adopted in the United States (6,
7). Redesigned care models that incorporate outpatient manage-
ment may reduce the risk of iatrogenic complications, with an
indirect reduction on mortality related to adverse events.
Limitations
A significant limitation to our analysis is the age of the data.
We studied patients admitted to hospitals between 1998 and
1999 because of a fortuitous linkage of claims, cancer reg-
istry, vital statistics, hospital characteristics, and access to nurse
survey data that are rarely available. Between then and now,
the speciation of organisms, the anti-infective agents used, the
patient populations at risk, and the use of colony-stimulating
factors to ameliorate neutropenia may have changed, but inpa-
tient management of febrile neutropenia has not changed ap-
preciably since the time of the study (37, 38). In addition, the
NCI-designated hospitals are identical between 1998 and 2010.
However, our findings should be interpreted cautiously and war-
rant investigation in more recent patient populations.
Because our primary data source was inpatient claims, we
did not have access to data regarding chemotherapy, receipt of
colony-stimulating factors or anti-infectives. Important clinical
covariates, such as performance and functional status, are also
missing. Our use of a state database restricted us to only four
hospitals that held NCI designation. These limitations are pre-
sented alongside a sizeable patient sample, a sample of hospitals
that is large and diverse, careful attention to risk adjustment of
the patient population, and an important inclusion of patients
below the age of 65 years that are rarely studied in claims-based
quality of cancer care studies.
Finally, because of the original study design, the measures
of nurse staffing, educational preparation, and practice environ-
ment were aggregated to the hospital level. Data specific to on-
cology units or ambulatory clinics were not available. However,
because of capacity problems, immunocompromised cancer pa-
tients with fever are often admitted to non-oncology units. Thus,
we feel that nursing measures aggregated to the hospital level
are appropriate for this study.
CONCLUSIONS AND SUMMARY
Mortality related to infectious complications is a significant
problem for patients with cancer. Understandably, characteris-
tics of individual patients are strongly associated with mortality.
Yet after adjusting for these clinical characteristics, patients who
received care in NCI-designated cancer centers were less likely
to die following this common complication. Not all patients can
or should be treated in NCI cancer centers, however. To improve
outcomes for these vulnerable patients, future studies should
first identify processes of care in place in high-performing cen-
ters and implement these efficacious interventions to other hos-
pitals and clinics.
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